None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with undifferentiated arthritis: inflammatory arthritis that does not fulfill the classification criteria for a more definitive diagnosis (e.g. 1987 ACR classification criteria for RA ) 2. Age >= 20 years old 3. Symptom duration < 1 year
Exclusion criteria
Exclusion criteria: 1. Patients who have received disease-modifying anti-rheumatic drugs or corticosteroids within 3 months 2. Patients with chronic inflammatory diseases: systemic lupus erythematosus, inflammatory myositis, systemic sclerosis, vasculitis, spondyloarthropathy, chronic tophaceous gout 3. Patients with severe systemic diseases - malignancy within 5 years - severe, uncontrolled cardiovascular, gastrointestinal, pulmonary, endocrine, hematology, neurologic disorder - history of severe trauma or major operation within 8 weeks - drug abuser 4. Pregnancy or patients willing to pregnant 5. Abnormal laboratory findings WBC 68 IU/L, ALT > 92 IU/L, T.bil > 2.4 mg/dL, Cr > 1.4 mg/dL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of progression from undifferentiated arthritis to rheumatoid arthritis | — |
Secondary
| Measure | Time frame |
|---|---|
| Health Assessment Questionaire score;disease activity score;radiologyc damage - Modified Sharp/Van der Heije score | — |
Countries
Korea, Republic of
Contacts
Yonsei University